University of Tennessee-Chattanooga: Study Results Published in Prestigious 'New England Journal of Medicine'
June 20, 2020
June 20, 2020
CHATTANOOGA, Tennessee, June 20 -- The University of Tennessee's Chattanooga Campus issued the following news release:
The prescription drug hydroxychloroquine has been in the news in recent months thanks to the COVID-19 global pandemic.
Hydroxychloroquine has successfully been used to treat lupus and rheumatoid arthritis and to prevent and treat malaria by killing the parasites that cause that disease. Since the drug has been beneficial in fighting off other viral . . .
The prescription drug hydroxychloroquine has been in the news in recent months thanks to the COVID-19 global pandemic.
Hydroxychloroquine has successfully been used to treat lupus and rheumatoid arthritis and to prevent and treat malaria by killing the parasites that cause that disease. Since the drug has been beneficial in fighting off other viral . . .